Parsons Capital Management »

Relmada Therapeutics shares owned by Parsons Capital Management

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Parsons Capital Management from 13F filings

Historical chart of Parsons Capital Management investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Parsons Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Parsons Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.5M 974k 4.65
2023-12-31 $3.9M 950k 4.14
2023-09-30 $2.9M 974k 3.00
2023-06-30 $2.1M 873k 2.46
2023-03-31 $1.6M 722k 2.26
2022-12-31 $1.7M 496k 3.49
2022-09-30 $19M 504k 37.02
2022-06-30 $9.6M 504k 18.99
2022-03-31 $14M 503k 26.99
2021-12-31 $11M 503k 22.53
2021-09-30 $12M 473k 26.21
2021-06-30 $14M 450k 32.01
2021-03-31 $16M 451k 35.21
2020-12-31 $15M 452k 32.07
2020-09-30 $17M 455k 37.62
2020-06-30 $20M 454k 44.75
2020-03-31 $15M 426k 34.11
2019-12-31 $14M 367k 39.00